MiR322 mediates cardioprotection against ischemia/reperfusion injury via FBXW7/notch pathway

Zixin Chen, Xuan Su, Yan Shen, Yue Jin, Tong Luo, Il-man Kim, Neal Lee Weintraub, Yao Liang Tang

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Myocardial ischemia/reperfusion (MI/R) causes loss of cardiomyocytes via oxidative stress-induced cardiomyocyte apoptosis. miR322, orthologous to human miR-424, was identified as an ischemia-induced angiogenic miRNA, but its cellular source and function in the setting of acute MI/R remains largely unknown. Using LacZ-tagged miR322 cluster reporter mice, we observed that vascular endothelial cells are the major cellular source of the miR322 cluster in adult hearts. Moreover, miR322 levels were significantly reduced in the heart at 24 h after MI/R injury. Intramyocardial injection of mimic-miR322 significantly diminished cardiac apoptosis (as determined by expression levels of active caspase 3 by Western blot analysis and immunostaining for TUNEL) and reduced infarct size by about 40%, in association with reduced FBXW7 and increased active Notch 1 levels in the ischemic hearts. FBXW7, which is an ubiquitin ligase that is crucial for activated Notch1 turnover, was identified as a direct target of miR322 via FBXW7 3’UTR reporter assay. Co-injection of FBXW7 plasmid with mimic-miR322 in ischemic hearts abolished the effect of mimic-miR322 to reduce apoptosis and infarct size in MI/R hearts. These data identify FBXW7 as a direct target of miR322 and suggest that miR322 could have potential therapeutic application for cardioprotection against ischemia/reperfusion-induced injury.

Original languageEnglish (US)
Pages (from-to)67-74
Number of pages8
JournalJournal of molecular and cellular cardiology
Volume133
DOIs
StatePublished - Aug 1 2019

Fingerprint

Reperfusion Injury
Myocardial Reperfusion
Myocardial Ischemia
Apoptosis
Cardiac Myocytes
Myocardial Reperfusion Injury
Injections
In Situ Nick-End Labeling
Ligases
Ubiquitin
MicroRNAs
Caspase 3
Oxidative Stress
Plasmids
Ischemia
Endothelial Cells
Western Blotting
Therapeutics

Keywords

  • Apoptosis
  • FBXW7
  • Ischemia
  • Notch
  • Reperfusion
  • miR322

ASJC Scopus subject areas

  • Molecular Biology
  • Cardiology and Cardiovascular Medicine

Cite this

MiR322 mediates cardioprotection against ischemia/reperfusion injury via FBXW7/notch pathway. / Chen, Zixin; Su, Xuan; Shen, Yan; Jin, Yue; Luo, Tong; Kim, Il-man; Weintraub, Neal Lee; Tang, Yao Liang.

In: Journal of molecular and cellular cardiology, Vol. 133, 01.08.2019, p. 67-74.

Research output: Contribution to journalArticle

@article{0871c738835c4fb199a73f417844433c,
title = "MiR322 mediates cardioprotection against ischemia/reperfusion injury via FBXW7/notch pathway",
abstract = "Myocardial ischemia/reperfusion (MI/R) causes loss of cardiomyocytes via oxidative stress-induced cardiomyocyte apoptosis. miR322, orthologous to human miR-424, was identified as an ischemia-induced angiogenic miRNA, but its cellular source and function in the setting of acute MI/R remains largely unknown. Using LacZ-tagged miR322 cluster reporter mice, we observed that vascular endothelial cells are the major cellular source of the miR322 cluster in adult hearts. Moreover, miR322 levels were significantly reduced in the heart at 24 h after MI/R injury. Intramyocardial injection of mimic-miR322 significantly diminished cardiac apoptosis (as determined by expression levels of active caspase 3 by Western blot analysis and immunostaining for TUNEL) and reduced infarct size by about 40{\%}, in association with reduced FBXW7 and increased active Notch 1 levels in the ischemic hearts. FBXW7, which is an ubiquitin ligase that is crucial for activated Notch1 turnover, was identified as a direct target of miR322 via FBXW7 3’UTR reporter assay. Co-injection of FBXW7 plasmid with mimic-miR322 in ischemic hearts abolished the effect of mimic-miR322 to reduce apoptosis and infarct size in MI/R hearts. These data identify FBXW7 as a direct target of miR322 and suggest that miR322 could have potential therapeutic application for cardioprotection against ischemia/reperfusion-induced injury.",
keywords = "Apoptosis, FBXW7, Ischemia, Notch, Reperfusion, miR322",
author = "Zixin Chen and Xuan Su and Yan Shen and Yue Jin and Tong Luo and Il-man Kim and Weintraub, {Neal Lee} and Tang, {Yao Liang}",
year = "2019",
month = "8",
day = "1",
doi = "10.1016/j.yjmcc.2019.05.020",
language = "English (US)",
volume = "133",
pages = "67--74",
journal = "Journal of Molecular and Cellular Cardiology",
issn = "0022-2828",
publisher = "Academic Press Inc.",

}

TY - JOUR

T1 - MiR322 mediates cardioprotection against ischemia/reperfusion injury via FBXW7/notch pathway

AU - Chen, Zixin

AU - Su, Xuan

AU - Shen, Yan

AU - Jin, Yue

AU - Luo, Tong

AU - Kim, Il-man

AU - Weintraub, Neal Lee

AU - Tang, Yao Liang

PY - 2019/8/1

Y1 - 2019/8/1

N2 - Myocardial ischemia/reperfusion (MI/R) causes loss of cardiomyocytes via oxidative stress-induced cardiomyocyte apoptosis. miR322, orthologous to human miR-424, was identified as an ischemia-induced angiogenic miRNA, but its cellular source and function in the setting of acute MI/R remains largely unknown. Using LacZ-tagged miR322 cluster reporter mice, we observed that vascular endothelial cells are the major cellular source of the miR322 cluster in adult hearts. Moreover, miR322 levels were significantly reduced in the heart at 24 h after MI/R injury. Intramyocardial injection of mimic-miR322 significantly diminished cardiac apoptosis (as determined by expression levels of active caspase 3 by Western blot analysis and immunostaining for TUNEL) and reduced infarct size by about 40%, in association with reduced FBXW7 and increased active Notch 1 levels in the ischemic hearts. FBXW7, which is an ubiquitin ligase that is crucial for activated Notch1 turnover, was identified as a direct target of miR322 via FBXW7 3’UTR reporter assay. Co-injection of FBXW7 plasmid with mimic-miR322 in ischemic hearts abolished the effect of mimic-miR322 to reduce apoptosis and infarct size in MI/R hearts. These data identify FBXW7 as a direct target of miR322 and suggest that miR322 could have potential therapeutic application for cardioprotection against ischemia/reperfusion-induced injury.

AB - Myocardial ischemia/reperfusion (MI/R) causes loss of cardiomyocytes via oxidative stress-induced cardiomyocyte apoptosis. miR322, orthologous to human miR-424, was identified as an ischemia-induced angiogenic miRNA, but its cellular source and function in the setting of acute MI/R remains largely unknown. Using LacZ-tagged miR322 cluster reporter mice, we observed that vascular endothelial cells are the major cellular source of the miR322 cluster in adult hearts. Moreover, miR322 levels were significantly reduced in the heart at 24 h after MI/R injury. Intramyocardial injection of mimic-miR322 significantly diminished cardiac apoptosis (as determined by expression levels of active caspase 3 by Western blot analysis and immunostaining for TUNEL) and reduced infarct size by about 40%, in association with reduced FBXW7 and increased active Notch 1 levels in the ischemic hearts. FBXW7, which is an ubiquitin ligase that is crucial for activated Notch1 turnover, was identified as a direct target of miR322 via FBXW7 3’UTR reporter assay. Co-injection of FBXW7 plasmid with mimic-miR322 in ischemic hearts abolished the effect of mimic-miR322 to reduce apoptosis and infarct size in MI/R hearts. These data identify FBXW7 as a direct target of miR322 and suggest that miR322 could have potential therapeutic application for cardioprotection against ischemia/reperfusion-induced injury.

KW - Apoptosis

KW - FBXW7

KW - Ischemia

KW - Notch

KW - Reperfusion

KW - miR322

UR - http://www.scopus.com/inward/record.url?scp=85066787335&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85066787335&partnerID=8YFLogxK

U2 - 10.1016/j.yjmcc.2019.05.020

DO - 10.1016/j.yjmcc.2019.05.020

M3 - Article

AN - SCOPUS:85066787335

VL - 133

SP - 67

EP - 74

JO - Journal of Molecular and Cellular Cardiology

JF - Journal of Molecular and Cellular Cardiology

SN - 0022-2828

ER -